End-of-day quote
Shenzhen S.E.
03:30:00 13/05/2024 am IST
|
5-day change
|
1st Jan Change
|
8.02
CNY
|
-0.62%
|
|
+3.75%
|
-10.39%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
2,513
|
3,616
|
2,881
|
3,419
|
3,042
|
-
|
Enterprise Value (EV)
1 |
2,513
|
3,616
|
2,881
|
3,419
|
3,042
|
3,042
|
P/E ratio
|
149
x
|
87.1
x
|
104
x
|
136
x
|
30.3
x
|
24.3
x
|
Yield
|
-
|
-
|
-
|
-
|
0.37%
|
0.5%
|
Capitalization / Revenue
|
-
|
-
|
-
|
6.15
x
|
3.18
x
|
2.47
x
|
EV / Revenue
|
-
|
-
|
-
|
6.15
x
|
3.18
x
|
2.47
x
|
EV / EBITDA
|
-
|
-
|
-
|
-
|
19.6
x
|
16.3
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
-
|
-
|
-
|
-
|
2.75
x
|
2.48
x
|
Nbr of stocks (in thousands)
|
3,17,267
|
3,66,000
|
3,68,352
|
3,81,990
|
3,79,338
|
-
|
Reference price
2 |
7.921
|
9.879
|
7.820
|
8.950
|
8.020
|
8.020
|
Announcement Date
|
26/04/21
|
25/04/22
|
25/04/23
|
24/04/24
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
-
|
-
|
-
|
555.8
|
957.1
|
1,230
|
EBITDA
1 |
-
|
-
|
-
|
-
|
155
|
187
|
EBIT
1 |
-
|
-
|
-
|
-
|
120
|
155
|
Operating Margin
|
-
|
-
|
-
|
-
|
12.54%
|
12.6%
|
Earnings before Tax (EBT)
1 |
-
|
-
|
-
|
-
|
120
|
155
|
Net income
1 |
16.99
|
38.88
|
27.67
|
24.34
|
100.5
|
127.5
|
Net margin
|
-
|
-
|
-
|
4.38%
|
10.5%
|
10.37%
|
EPS
2 |
0.0533
|
0.1134
|
0.0753
|
0.0657
|
0.2650
|
0.3300
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
0.0300
|
0.0400
|
Announcement Date
|
26/04/21
|
25/04/22
|
25/04/23
|
24/04/24
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-
|
-
|
8.98%
|
10.3%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
5.9%
|
6.6%
|
Assets
1 |
-
|
-
|
-
|
-
|
1,703
|
1,932
|
Book Value Per Share
2 |
-
|
-
|
-
|
-
|
2.920
|
3.240
|
Cash Flow per Share
2 |
-
|
-
|
-
|
-
|
0.1500
|
0.1700
|
Capex
1 |
-
|
-
|
-
|
-
|
47
|
46
|
Capex / Sales
|
-
|
-
|
-
|
-
|
4.91%
|
3.74%
|
Announcement Date
|
26/04/21
|
25/04/22
|
25/04/23
|
24/04/24
|
-
|
-
|
Last Close Price
8.02
CNY Average target price
11.74
CNY Spread / Average Target +46.38% Consensus |
1st Jan change
|
Capi.
|
---|
| -10.39% | 424M | | +26.70% | 44.96B | | -0.69% | 42.65B | | +46.00% | 41.85B | | -5.31% | 29.04B | | +9.39% | 26.08B | | -21.69% | 19.03B | | +6.45% | 12.75B | | +27.56% | 12.06B | | -3.29% | 11.75B |
Other Biotechnology & Medical Research
|